Clinical Trials Browser

Phase NA × INDUSTRY × Sunitinib × Clear all

NCT00428220 2019-06-27

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Adenoma, Islet Cell, Somatostatinoma, Thyroid Neoplasms, Gastrointestinal Stromal Tumors

NCT00443534 2013-05-24

A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.

Phase NA Completed

123 enrolled 6 charts

Tumor-Agnostic

Neoplasms

NCT00798889 2013-01-21

Rollover Protocol for Prior SU011248 Protocols

Phase NA Completed

314 enrolled 6 charts

Other solid neoplasm

Solid Tumors